Using Legionella-amoeba co-evolution to reveal new modes of immunity and pathogenesis
利用军团菌-阿米巴共同进化揭示新的免疫模式和发病机制
基本信息
- 批准号:10392755
- 负责人:
- 金额:$ 1.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-01 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAmoeba genusAnimalsAnti-Bacterial AgentsAntibioticsAttentionBacteriaBacterial GenesBacterial InfectionsBacteriologyBiological ModelsBiologyCandidate Disease GeneCellsCellular biologyConflict (Psychology)CytosolDetectionDictyosteliumDiseaseDisease OutbreaksEnvironmentEukaryotic CellEvolutionGenesGeneticGenetic ScreeningGenetic TranscriptionGenomeGenomicsHealthHumanImmuneImmune responseImmune systemImmunityInfectionIronLeadLegionellaLegionella pneumophilaMammalian CellMicrobeModelingMolecularMolecular EvolutionNatural ImmunityOrganismOutcomePathogenesisPathway interactionsPlayPneumoniaPredispositionProteinsRaceResearchResourcesRoleStructureSystemTestingToll-like receptorsTrainingTransgenic OrganismsViral Pathogenesisarmbacterial fitnessbacterial geneticsbasecomparative genomicsexperienceexperimental studyfightingfitnessgenetic approachgenetic evolutiongenome-widegenome-wide analysishost-microbe interactionsimprintinnovationinterdisciplinary approachmanmembermicrobialmolecular shapemutantnovelnovel strategiesopportunistic pathogenpathogenpathogen genomepathogenic bacteriapressurepreventprogramsresidencetransposon sequencing
项目摘要
PROJECT SUMMARY
Legionella pneumophila is an opportunistic bacterial pathogen that causes outbreaks of a lethal, pneumonia-
like disease. Although human infections are evolutionary “dead ends” for these bacteria, Legionella
nevertheless carry extensive molecular arsenals to attack human cells due to their adaptation to their natural
hosts, environmental amoebae. Residence in amoebae also protects Legionella from antibiotics and other
efforts to eliminate the bacteria from man-made structures, perpetuating human outbreaks. Revealing how
Legionella exploits host amoebae—particularly steps vulnerable to disruption—therefore has direct benefits for
human health. This proposal will investigate how molecular “arms races” between Legionella and amoebae
have shaped the molecular toolkit of this pathogen, and address the specific hypothesis that Legionella
secreted effector proteins are engaged in arms races with amoeba immune pathways. The experimental
tractability and evolutionary resources available for Legionella and amoebae make this a powerful host-
microbe model system, where it is possible to test the functional consequences of evolutionary innovation in
both host and microbe. Aim 1 will investigate how Legionella has been impacted by such an arms race.
Evolutionary approaches will analyze this organism's enormous arsenal of molecular weaponry, the type IV
effectors, to identify genes and residues likely engaged in arms races with hosts. Bacterial genetics will then be
used to functionally test evolutionary hypotheses about which genes or residues are critical for pathogen
fitness. These studies will begin with the mavN gene, which appears to be engaged in an evolutionary “battle
for iron” within host cells. In addition to such competitions for resources, many pathogens have evolved
strategies to evade detection by host immune systems. High-throughput transposon-sequencing approaches
will be used to identify bacterial genes that are required for fitness within Dictyostelium amoebae, particularly
those that interact with amoeba immunity. These experiments will reveal which Legionella proteins have
experienced strong selective pressures in amoeba hosts. Aim 2 will examine the host genes likely to place
strong selective pressures on Legionella through studies of amoeba immune defenses. The Dictyostelium TirA
protein is related to Toll-like receptors in animals, and helps the amoebae to resist Legionella infection.
However, beyond these basic facts, almost nothing is known about amoeba immunity. This aim will further
characterize the activity of the TirA immune pathway, identifying additional members of the immune pathway
and transcriptional targets. Evolutionary and unbiased genetic approaches will highlight additional arms of the
amoeba immune response that respond to Legionella infection. The proposal will combine the applicant's
background in evolution, genetics, and host-microbe interactions with the Malik lab's expertise in evolutionary
arms races. This interdisciplinary approach will also provide her new training in bacteriology and amoebal
biology, to uncover how evolutionary arms races in the natural environment have armed Legionella for human
infections.
项目摘要
肺炎军团菌是一种机会性细菌病原体,可导致致命的肺炎爆发
喜欢疾病。尽管人类感染是这些细菌的进化“死胡同”,但军团菌
然而,由于其自然的适应
主持人,环境变形虫。 Amoebae的住所还保护军团菌免受抗生素和其他
从人造结构中消除细菌的努力,使人类爆发永存。揭示如何
军团explosits主持人变形虫(尤其是步骤易于破坏),因此有直接的好处
人类健康。该提议将调查军团菌和变形虫之间的分子“武器”如何
已经塑造了该病原体的分子工具包,并解决了军团菌的具体假设
分泌的效应蛋白参与具有变形虫免疫途径的武器种族。实验
可用于军团菌和变形虫的障碍性和进化资源使其成为强大的宿主 -
微生物模型系统,可以在其中测试进化创新的功能后果
主机和微生物。 AIM 1将调查该军备竞赛如何影响军团菌。
进化方法将分析该生物的巨大分子武器(IV型)
效应子,识别可能与宿主一起参加武器比赛的基因并保留基因。细菌遗传学将是
用于在功能上检验哪些基因或残差对于病原体至关重要的进化假设
健康。这些研究将从MAVN基因开始,MAVN基因似乎参与进化的“战斗”
对于宿主细胞内的铁。
通过宿主免疫系统逃避检测的策略。高通量转座子测序方法
将用于鉴定柱状脉冲中适应性所需的细菌基因,特别是
那些与变形虫免疫相互作用的人。这些实验将揭示哪些军团蛋白具有
Amoeba主持人经历了强烈的选择压力。 AIM 2将检查可能放置的宿主基因
通过研究变形虫免疫防御能力对军团菌的强烈选择压力。 dictyostelium tira
蛋白质与动物中的Toll样受体有关,并有助于抗变形虫抵抗军团菌感染。
但是,除了这些基本事实之外,几乎没有关于变形虫免疫的了解。这个目标将进一步
表征TIRA免疫途径的活性,识别免疫途径的其他成员
和转录目标。进化和公正的遗传方法将突出显示的其他臂
对军团菌感染反应的变形虫免疫反应。该提案将结合申请人的
演变,遗传学和宿主 - 微生物与Malik Lab的进化专业知识的背景
军备竞赛。这种跨学科的方法还将为她的细菌和变形虫提供新的培训
生物学,以发现自然环境中的进化武器种族如何为人类武装军团
感染。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
L. pneumophila resists its self-harming metabolite HGA via secreted factors and collective peroxide scavenging.
- DOI:10.1128/mbio.01207-23
- 发表时间:2023-10-31
- 期刊:
- 影响因子:6.4
- 作者:
- 通讯作者:
Eukaryotic CD-NTase, STING, and viperin proteins evolved via domain shuffling, horizontal transfer, and ancient inheritance from prokaryotes.
- DOI:10.1371/journal.pbio.3002436
- 发表时间:2023-12
- 期刊:
- 影响因子:9.8
- 作者:Culbertson, Edward M.;Levin, Tera C.
- 通讯作者:Levin, Tera C.
mSphere of Influence: How I Learned to Love Bacteria and their Tangled Evolutionary Tree.
- DOI:10.1128/msphere.00780-21
- 发表时间:2021-10-27
- 期刊:
- 影响因子:4.8
- 作者:Levin TC
- 通讯作者:Levin TC
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tera Catherine Levin其他文献
Tera Catherine Levin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Tera Catherine Levin', 18)}}的其他基金
The origins and evolution of eukaryotic antibacterial defenses
真核生物抗菌防御的起源和进化
- 批准号:
10711117 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Using Legionella-amoeba co-evolution to reveal new modes of immunity and pathogenesis
利用军团菌-阿米巴共同进化揭示新的免疫模式和发病机制
- 批准号:
10166988 - 财政年份:2020
- 资助金额:
$ 1.41万 - 项目类别:
Using Legionella-amoeba co-evolution to reveal new modes of immunity and pathogenesis
利用军团菌-阿米巴共同进化揭示新的免疫模式和发病机制
- 批准号:
10200673 - 财政年份:2020
- 资助金额:
$ 1.41万 - 项目类别:
相似海外基金
Defining mechanisms of mitotic spindle organization in Naegleria
耐格里虫有丝分裂纺锤体组织的定义机制
- 批准号:
10537005 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Defining cytoskeletal mechanisms driving cell motility in Naegleria
定义耐格里虫细胞驱动细胞运动的细胞骨架机制
- 批准号:
10510010 - 财政年份:2022
- 资助金额:
$ 1.41万 - 项目类别:
Elucidating pathways that regulate fungal keratitis pathogenesis
阐明调节真菌性角膜炎发病机制的途径
- 批准号:
10341206 - 财政年份:2020
- 资助金额:
$ 1.41万 - 项目类别:
Using Legionella-amoeba co-evolution to reveal new modes of immunity and pathogenesis
利用军团菌-阿米巴共同进化揭示新的免疫模式和发病机制
- 批准号:
10166988 - 财政年份:2020
- 资助金额:
$ 1.41万 - 项目类别:
Using Legionella-amoeba co-evolution to reveal new modes of immunity and pathogenesis
利用军团菌-阿米巴共同进化揭示新的免疫模式和发病机制
- 批准号:
10200673 - 财政年份:2020
- 资助金额:
$ 1.41万 - 项目类别: